Actinium Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Actinium Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Actinium Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 31.2M shares, a 13.8% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 31.2M +3.78M +13.8% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 30.6M +3.57M +13.2% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 29.4M +3.67M +14.3% Mar 31, 2024 10-Q 2024-04-26
Q4 2023 27.6M +1.96M +7.63% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 27.4M +2.2M +8.73% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 27M +2.11M +8.5% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 25.7M +3.59M +16.2% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 25.7M +3.53M +15.9% Dec 31, 2022 10-K 2024-03-29
Q3 2022 25.2M +3.18M +14.4% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 24.9M +3.78M +17.9% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 22.1M +2.9M +15.1% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 22.1M +4.61M +26.3% Dec 31, 2021 10-K 2023-03-31
Q3 2021 22M +8.44M +62.2% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 21.1M +7.92M +60.1% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 19.2M -156M -89% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 17.5M +12M +219% Dec 31, 2020 10-K 2022-03-25
Q3 2020 13.6M -151M -91.8% Sep 30, 2020 10-Q 2020-10-23
Q2 2020 13.2M -149M -91.9% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 175M +55.7M +46.8% Mar 31, 2020 10-Q 2020-06-30
Q4 2019 5.49M -110M -95.3% Dec 31, 2019 10-K 2021-03-31
Q3 2019 165M +54.2M +49.1% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 162M +51.6M +46.7% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 119M +8.82M +8% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 116M +35.6M +44.5% Dec 31, 2018 10-K 2020-05-08
Q3 2018 110M +30.4M +38% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 110M +51.9M +88.8% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 110M +53.2M +93% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 80.1M +24.3M +43.5% Dec 31, 2017 10-K 2019-03-15
Q3 2017 80M +32.3M +67.6% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 58.5M +11.2M +23.7% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 57.2M +12.2M +27.2% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 55.8M +11.7M +26.6% Dec 31, 2016 10-K 2018-03-16
Q3 2016 47.7M +5.83M +13.9% Sep 30, 2016 10-Q 2016-10-28
Q2 2016 47.3M +6.81M +16.8% Jun 30, 2016 10-Q 2016-07-29
Q1 2016 44.9M +9.22M +25.8% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 44.1M +14.1M +47% Dec 31, 2015 10-K 2017-03-16
Q3 2015 41.9M +12.3M +41.5% Sep 30, 2015 10-Q 2015-10-30
Q2 2015 40.5M +12.9M +46.7% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 35.7M +10.1M +39.7% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 30M +5.41M +22% Dec 31, 2014 10-K 2016-03-11
Q3 2014 29.6M +5.96M +25.2% Sep 30, 2014 10-Q 2014-10-31
Q2 2014 27.6M +4.02M +17% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 25.6M +4.17M +19.5% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 24.6M +3.17M +14.8% Dec 31, 2013 10-K 2015-03-16
Q3 2013 23.7M Sep 30, 2013 10-Q 2013-11-14
Q2 2013 23.6M Jun 30, 2013 10-Q 2013-08-13
Q1 2013 21.4M Mar 31, 2013 10-Q 2013-05-15
Q4 2012 21.4M +7.73M +56.5% Dec 31, 2012 10-K 2014-02-28
Q4 2011 13.7M +2.51M +22.5% Dec 31, 2011 10-K 2013-03-29
Q3 2011 11.2M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 11.2M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 11.2M Dec 31, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.